Alberta Cancer Foundation

Report to Our Donors 2025

Every month makes a difference

Share This Article

Monthly donors continue to make a lasting impact.

GivingHand iStock 2168991155 Caramel

Their generosity provides a steady lifeline for cancer care, research and essential programs throughout the year. Month after month, these gifts give the Alberta Cancer Foundation the flexibility to respond to evolving needs across the cancer system and support patients and families at every stage of their journey.

Monthly donors are among the Foundation’s most committed partners. Their ongoing support provides the stability that progress depends on, funding patient care, advancing innovative research and sustaining programs that ease the financial and emotional burden of cancer.

“Our monthly donors’ generosity provides stability, flexibility and hope,” says Wendy Beauchesne, CEO of the Alberta Cancer Foundation. “It allows care and innovation to move forward without pause and creates a powerful, lasting impact for Albertans facing cancer.”

This commitment has real impact. Monthly donors help bring advanced treatments to Albertans sooner, accelerate discovery and strengthen world-leading research across the province.

For many donors, monthly giving is a meaningful way to stand alongside Albertans facing cancer, not just once, but over time. Together, these gifts create stronger care today and a future filled with more hope.

Infographic showing: 6,000+ monthly donors. $2 million+ donated by monthly donors last year. 241 communities across Alberta.
Sarah Parkin, philanthropy officer at the Alberta Cancer Foundation and Sky Mitchell, CEO of Basecamp Resorts, tour the Mobile Breast Screening Unit in Canmore.
RTD2025

Mammography on the move

Mobile breast screening units are bringing mammograms directly into communities.

Dr. Michael Chu and Mike Zurwell smiling at the camera.
RTD2025

Made-in-Alberta cellular therapy

An Alberta-led CAR T-cell clinical trial is delivering faster, more affordable treatment for Albertans facing blood cancer.